Addendum
Sipavibart (pre exposure prophylaxis of COVID 19) – 2nd Addendum to Project A25-28
Report documents
-
Addendum
Sipavibart (Präexpositionsprophylaxe von COVID-19) - 2. Addendum zum Projekt A25-28
Additional information
Federal Joint Committee (G-BA)
07-08-2025 A G-BA decision was published.
G-BA documents on this decision
Project details
- Project no.
- G25-21
- Commission
- Commission awarded on 24.06.2025 by the Federal Joint Committee (GBA).
- Report type
- Addendum
- Status
- Commission completed
- Department/Division
- Health Economics
- Topic
- Immune system and infections
- Note
-
If, in the course of the discussions on a commission of the GBA, a need for further revision arises, IQWiG submits an addendum. The GBA decides on the number of patients in the SHI target population.
- DOI
https://doi.org/10.60584/G25-21
Connected Projects
-
Dossier assessment
Sipavibart (pre-exposure prophylaxis of COVID-19) – Benefit assessment according to §35a Social Code Book V
Status: Commission completed